⚠ The Multiple Still Prices In a LotModerate threat

Adyen (ADYEN) — threat to the moat

De-rated from ~150x to ~28x — back to earth, still a growth stock's promise to keep.

Even after a dramatic de-rating, Adyen's valuation still prices in substantial continued growth, which means the stock remains exposed to any disappointment in the growth the moat is meant to protect. Adyen was once a market darling trading at nosebleed multiples — around 150 times earnings and 70 times sales at its 2021 peak1 — as investors extrapolated its rapid, profitable growth indefinitely. The subsequent de-rating has been severe: to around 25 times earnings and 11 times net revenue today2, as growth normalized, the 2023 scare punctured the invincibility narrative, and competition worries mounted. That de-rating has made the stock far more reasonably valued than at its peak. But around 25 times earnings for a company growing net revenue in the low-20s percent is still a growth valuation, not a value one — it prices Adyen as a quality compounder that will keep compounding, and it leaves real downside if the growth disappoints.

What today's price assumesPrice to trailing earningsabout 25xPrice to trailing net revenueabout 11xForward price to earningsabout 21x2026 growth guidance, constant currency21-23%stockanalysis.com, September 2026; Adyen H1 2026 results
About 25 times earnings still requires growth above 20% for years; the guidance says so for 2026.

This valuation sensitivity is the financial expression of the narrow moat. Because the price embeds continued high growth, and because the moat — while real — is contested by formidable competition and subject to take-rate pressure and cyclical margins, the stock is vulnerable to exactly the kind of growth wobble that competition or a maturing base can produce, as 2023 showed in the most dramatic way. A wide-moat business whose growth was assured could carry such a multiple comfortably; Adyen's narrow moat, contested and cyclical, makes the growth less certain and the multiple therefore riskier. The de-rating has genuinely improved the risk-reward — Adyen at 25 times earnings is a far better proposition than at 150, and for a business of this quality and profitability the current multiple is not obviously expensive. But an investor should recognize that the valuation still requires the growth to continue, that the moat protecting that growth is narrow and contested, and that the market has already shown, in 2023, how violently it will punish any interruption — so the price, though far more reasonable than before, still asks the compounding to persist, and still carries the risk that a narrow moat in a competitive market cannot guarantee it.

References
  1. Third-party estimate2021 peak: ~150x earnings, ~70x sales.
    Market data (stockanalysis.com) - ~€861/share on 31.57M shares, ~€28.5B market cap, ~25x trailing earnings (net income €1.13B), ~11x trailing net revenue (€2.57B), ~21x forward; 52-week range €772.40-€1,600.80 — September 2026 · source ↗
  2. Third-party estimateToday: ~25x earnings, ~11x net revenue.
    Market data (stockanalysis.com) - ~€861/share on 31.57M shares, ~€28.5B market cap, ~25x trailing earnings (net income €1.13B), ~11x trailing net revenue (€2.57B), ~21x forward; 52-week range €772.40-€1,600.80 — September 2026 · source ↗
Sources
Generated September 23, 2026